From: Nuclear basic fibroblast growth factor regulates triple-negative breast cancer chemo-resistance
TNBC patients | Chemotherapy | Nuclear bFGF(+) cells pre-chemotherapy (%) | Nuclear bFGF(+) cells post-chemotherapy (%) | Trend (post-chemotherapy versus pre-chemotherapy) |
---|---|---|---|---|
1 | ACT | 50 | 90 | Increase |
2 | TC | 1 | 50 | Increase |
3 | AC | 0 | 100 | Increase |
4 | TAC | 100 | 100 | = |
5 | AC | 100 | 100 | = |
6 | AC + 1 × paclitaxel | 30 | 20 | Decrease |
7 | ACT | 70 | 20 | Decrease |
8 | ACT | 90 | 25 | Decrease |
9 | AC + 1 × paclitaxel | 100 | 15 | Decrease |